Boston Scientific Corp (WBO:BSXC)
€ 68.5 1 (1.48%) Market Cap: 100.27 Bil Enterprise Value: 108.32 Bil PE Ratio: 61.71 PB Ratio: 5.42 GF Score: 73/100

Q3 2019 Boston Scientific Corp Earnings Call Transcript

Oct 23, 2019 / 12:00PM GMT
Release Date Price: €36.61 (+5.17%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Boston Scientific Q3 2019 Earnings Call. (Operator Instructions) As a reminder, today's call is being recorded.

I will now turn the call over to your host, Susan Lisa. Please go ahead.

Susan Vissers Lisa
Boston Scientific Corporation - VP of IR

Thanks, Kevin. Good morning, everyone, and thanks for joining us. With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer; and Dan Brennan, Executive Vice President and Chief Financial Officer.

We issued a press release earlier this morning announcing our Q3 2019 results, which included reconciliations of the non-GAAP measures used in the release. We have posted a copy of that release as well as reconciliations of the non-GAAP measures used in today's call to the Investor Relations section of our website under the heading Financials & Filings.

The duration of this morning's call will be approximately 1 hour. Mike will provide strategic and revenue highlights of Q3 '19. Dan will review the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot